Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.40 |
| ▸ | NR1I3 | Q14994 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.37 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.37 |
| ▸ | HEXA | P06865 | 1/20 | 0.37 |
| ▸ | HEXB | P07686 | 1/20 | 0.37 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.37 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL488939 | 0.90 | ACHE (0.50) | L3MBTL1CNR1CNR2ACHERAB9A | |
| SCHEMBL20809931 | 0.86 | CNR1 (0.49) | L3MBTL1CNR1CNR2ACHERAB9A | |
| SCHEMBL7487894 | 0.86 | ACHE (0.46) | L3MBTL1CNR1CNR2ACHERAB9A | |
| SCHEMBL12415346 | 0.84 | BRD9 (0.40) | L3MBTL1ACHETSHRHPGDKMT2A | |
| SCHEMBL9612423 | 0.81 | MAPK1 (0.43) | L3MBTL1CNR1CNR2ACHERAB9A | |
| SCHEMBL18904909 | 0.81 | CNR1 (0.41) | L3MBTL1CNR1CNR2ACHERAB9A | |
| SCHEMBL25656537 | 0.81 | RAB9A (0.46) | L3MBTL1CNR1CNR2ACHERAB9A | |
| SCHEMBL12415335 | 0.80 | ESR2 (0.40) | CNR1ACHEKMT2AALDH1A1 | |
| SCHEMBL29665066 | 0.80 | ESR2 (0.40) | CNR1ACHEKMT2AALDH1A1 | |
| SCHEMBL8853507 | 0.79 | RAB9A (0.43) | L3MBTL1CNR1CNR2ACHERAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8283855-B2 | Method for synthesis of anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-09 | — | — | US | disclosed |
| US-8283855-B2 | Method for synthesis of anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-09 | — | — | US | disclosed |
| US-20110172441-A1 | METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-07-14 | — | — | US | disclosed |
| US-20110172441-A1 | METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172441-A1 | METHOD FOR SYNTHESIS OF ANTHRACENE DERIVATIVE | CYP1A1, AHR, CYP2C9 | L3MBTL1 4147/4885CNR1 2493/4885CNR2 2965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.